The significance of therapeutic drug monitoring in detecting low medication adherence in patients with cancer: A case study of cabozantinib

Abstract

Key Clinical Message Maintaining good medication adherence is important for providing desirable outcomes from medication therapy. We showed that therapeutic drug monitoring (TDM) contributed to the identification of low medication adherence to cabozantinib in a patient with cancer. We present an educational case to assist with understanding TDM in a patient with cancer.

Keywords

• cabozantinib
• high performance liquid chromatography
• kidney cancer
• medication compliance
• therapeutic drug monitoring
• tyrosine kinase inhibitor